Showing 551 articles

  • 90TEN strengthens senior management team to enhance behavioural science and creative services

    28 Aug 2020| Nola Cadman

    Mark Lakeram, previously 90TEN’s Director of Scientific Services, will be taking on a new role as Group Director, Head of Behavioural Science, to lead 90TEN’s behavioural science function across all divisions of the company.

  • Coulter Partners secures Chief Medical Officer

    28 Aug 2020| Nola Cadman

    The appointment of Oliver Gödje, MD, PhD, as Chief Medical Officer. Dr Gödje replaces Gijs Klarenbeek, MD, who remains with Sequana Medical as Senior Medical Advisor.

  • PureTech Founded Entity Vor Biopharma Appoints John King as Chief Commercial Officer

    28 Aug 2020| Nola Cadman

    Vor Biopharma aims to transform the lives of cancer patients by pioneering engineered hematopoietic stem cell (eHSC) therapies.

  • Pharmaceutical Companies

    27 Aug 2020| Mike Wood

    Europe's Largest Pharma Job Board, works with some of the world's largest pharmaceutical companies, as well as clinical research organisations (CROs), biotech companies and companies within the healthcare sector and Life Sciences generally:

  • Coulter Partners secures Chief Medical Officer for Sequana Medical

    25 Aug 2020| Alison James

    Coulter Partners was very pleased to partner recently with Sequana Medical NV (Euronext Brussels: SEQUA), an innovator in the management of fluid overload in liver disease, malignant ascites and heart failure, to secure the appointment of Oliver Gödje, MD, PhD, as Chief Medical Officer.

  • Merck Appoints Liz Henderson as new Regional Vice President, Merck Biopharma APAC

    21 Aug 2020| Nola Cadman

    Merck, a leading science and technology company, operates across healthcare, life science and performance materials. Around 57,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live.

  • GC Aesthetics to see Global Market Recovery with Ms. Fara Naomi Macias as “GCA Head of Marketing”

    21 Aug 2020| Nola Cadman

    GC Aesthetics is an established global medical technology company that develops, manufactures in-house and markets a comprehensive range of proprietary aesthetic products that empower patients to feel confident and secure in their personal journey.

  • OKYO Pharma Limited ("OKYO" or the "Company") - Appointment of Dr. Napoleone Ferrara to Serve on Its Scientific Advisory Board

    21 Aug 2020| Nola Cadman

    OKYO, the life sciences and biotechnology company, focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and chronic pain, is pleased to announce that that Dr. Napoleone Ferrara, MD

  • Byondis Announces Appointment of Chief Financial Officer

    21 Aug 2020| Nola Cadman

    Byondis B.V. (formerly Synthon Biopharmaceuticals B.V.) is pleased to announce the appointment of Robbert Van Heekeren as chief financial officer. Mr. Van Heekeren

  • What does a Medical Writer do?

    20 Aug 2020| Mike Wood

    A Medical Writer is a specific type of science writer working for a pharmaceutical company, contract research organisations (CROs), or a communication agency. The job of a medical writer entails documenting and communicating scientific research in a well written, standards-compliant way, that medical professionals can easily read and digest.

  • Clasado strengthens commercial presence of Bimuno® with EU Sales & Marketing Director appointment

    13 Aug 2020| Nola Cadman

    Clasado is a leading biotechnology pioneer in the development of microbiome science producing prebiotic ingredients and consumer products aimed at gastrointestinal wellness destined for the food and healthcare sectors.

  • Nanoform convenes EGM to elect Cynthia Schwalm as board member

    13 Aug 2020| Nola Cadman

    Nanoform is an innovative nanoparticle medicine enabling company. Nanoform works together with pharma and biotech partners globally to reduce attrition in clinical trials and enhance their molecules’ formulation performance through its nanoforming services.

  • SK pharmteco announces General Manager to SK biotek Ireland

    13 Aug 2020| Nola Cadman

    SK pharmteco is the single customer-facing team comprised of SK biotek Ireland, AMPAC Fine Chemicals, SK biotek Korea. Creating substantial market synergies in the API CDMO space by combining highly complementary assets and expertise, this union enables us to provide the highest-quality services to our customers.

  • Nordic Nanovector Appoints Dr Christine Wilkinson Blanc as Chief Medical Officer

    13 Aug 2020| Nola Cadman

    Nordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care. The Company aspires to become a leader in the development of targeted therapies for haematological cancers.

  • NBE-Therapeutics Appoints Erich Schlick as Chairman of the Board of Directors

    13 Aug 2020| Nola Cadman

    NBE-Therapeutics is a privately-owned Swiss biotech company based in Basel and founded in 2012 with the vision of developing next-generation immune-stimulatory antibody drug conjugate (iADC™) products. NBE advances its products to clinical proof of concept with the goal of improving treatment options for cancer patients.

  • Dr James Khodabakhsh MD named Chairman of the Scientific Advisory Board at OKYO Pharma Ltd

    13 Aug 2020| Nola Cadman

    OKYO Pharma Limited (LSE: OKYO) is a life sciences and biotechnology company admitted to listing on the standard segment of the Official List of the UK Financial Conduct Authority and to trading on the Main Market for listed securities of the London Stock Exchange plc. OKYO is focusing on the discovery and development of novel molecules to treat inflammatory dry eye diseases and chronic pain.

  • Pharnext Appoints Adrian Hepner, M.D., Ph.D. as Chief Medical Officer

    12 Aug 2020| PharmiWeb Editor

    Distinguished industry leader to head clinical development programs, including PXT3003 in Phase III for treatment of Charcot-Marie-Tooth disease type 1A (CMT1A)

  • Michael Van den Bossche appointed new joint Managing Director of Romaco Innojet

    6 Aug 2020| Nola Cadman

    Michael Van den Bossche has just been appointed new Managing Director of Romaco Innojet. He will share the running of the company with Bastian Käding, who has been at the helm of Romaco Innojet since 2018.

  • PharmaLex strengthens its commercial organization

    6 Aug 2020| Nola Cadman

    The appointment of Sébastien Schmitt will further consolidate PharmaLex’s commercial offerings for our clients.

  • Valo Therapeutics Appoints Industry Veteran Paul Higham as CEO

    6 Aug 2020| Nola Cadman

    Valo Therapeutics (Helsinki and Oxford) is an immuno-oncology company that is developing tumor antigen-coated oncolytic viruses as anti-cancer therapeutics